Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

AlloVir (ALVR) News Today

AlloVir logo
$5.12 +0.29 (+6.00%)
As of 05/21/2026

ALVR Latest News

Kalaris Announces Closing of Merger with AlloVir
Kalaris, AlloVir announce stockholder approval of merger
Allovir's Vikas Sinha sells shares worth $3,052
Allovir's chief accounting officer sells $967 in stock
Allovir's general counsel sells $494 in stock
AlloVir trading halted, news pending
AlloVir Appoints Vikas Sinha as New CEO
AlloVir (NASDAQ:ALVR) Stock, Option Chain
AlloVir and Kalaris Merge to Advance Retinal Therapies
AlloVir to combine with Kalaris Therapeutics in all-stock transaction
Wasatch Small Cap Growth Institutional
Octagon Capital Advisors LP Increases Stake in AlloVir Inc
Wasatch Small Cap Growth Investor
ALVR Stock Earnings: AlloVir Misses EPS for Q1 2024
AlloVir, Inc. (ALVR)
ALVR Stock Earnings: AlloVir Misses EPS for Q4 2023
Get AlloVir News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALVR Media Mentions By Week

ALVR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALVR
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

ALVR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALVR Articles
This Week

0

0

ALVR Articles
Average Week

Get the Latest News and Ratings for ALVR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for AlloVir and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners